Acute Heart Failure Is a Malignant Process: But We Can Induce Remission
Gad Cotter1,2,3, Beth A Davison1,2,3, Carolyn S P Lam4,5
1Heart Initiative Durham NC.
Journal of the American Heart Association
|October 27, 2023
Summary
Early, aggressive treatment of acute heart failure can induce remission. Prompt therapy with full medication doses improves outcomes and reduces healthcare costs, but implementation gaps remain.
Area of Science:
- Cardiology
- Public Health
Background:
- Acute heart failure affects over 10 million people annually worldwide.
- High early readmission and mortality rates (>30%) post-discharge signify a critical health challenge.
- Acute heart failure is a major contributor to global healthcare expenditures.
Purpose of the Study:
- To highlight recent findings on inducing remission in acute heart failure.
- To emphasize the importance of rapid, full-dose medication therapy.
- To call for collaborative efforts to bridge implementation gaps.
Main Methods:
- Review of studies published within the last two years.
- Analysis of therapeutic strategies for acute heart failure.
- Evaluation of the safety and efficacy of rapid, full-dose medication initiation.
Main Results:
- Rapid institution of full-dose effective medications at the first acute heart failure episode can induce remission.
- This therapeutic approach has been demonstrated to be safe and effective in multiple studies.
- Successful implementation can lead to durable remissions for patients.
Conclusions:
- Prompt, aggressive medical management is key to improving acute heart failure outcomes.
- Addressing implementation barriers is crucial for widespread adoption of effective therapies.
- Multistakeholder collaboration is essential to improve patient care and reduce the burden of acute heart failure.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.5K
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.5K
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
01:30Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
01:29Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
01:30Heart Failure IV: Classification and Diagnostic Evaluation
18
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
18